Single-Cell Quantification of a Highly Biocompatible Dinuclear Iridium(III) Complex for Photocatalytic Cancer Therapy

被引:69
作者
Fan, Zhongxian [1 ]
Rong, Yi [2 ]
Sadhukhan, Tumpa [3 ]
Liang, Shaoxia [4 ]
Li, Wenqing [1 ]
Yuan, Zhanxiang [5 ]
Zhu, Zilin [1 ]
Guo, Shunwen [2 ]
Ji, Shaomin [5 ]
Wang, Jinquan [2 ]
Kushwaha, Rajesh [6 ]
Banerjee, Samya [6 ]
Raghavachari, Krishnan [3 ]
Huang, Huaiyi [1 ]
机构
[1] Sun Yat Sen Univ, Sch Pharmaceut Sci Shenzhen, Shenzhen Campus Sun Yat Sen Univ, Shenzhen 518107, Peoples R China
[2] Guangdong Pharmaceut Univ, Sch Biosci & Biopharmaceut, Guangdong Prov Key Lab Biotechnol Drug Candidates, Guangzhou 510006, Peoples R China
[3] Indiana Univ Bloomington, Dept Chem, Bloomington, IN 47405 USA
[4] PerkinElmer Inc, Guangzhou 510370, Peoples R China
[5] Guangdong Univ Technol, Light Ind & Chem Engn Coll, Guangzhou 510006, Peoples R China
[6] Indian Inst Technol BHU, Dept Chem, Varanasi 221005, UP, India
基金
美国国家科学基金会; 中国国家自然科学基金;
关键词
Antitumor agents; Iridium Complexes; Photocatalysis; Photodynamic Therapy; Single-Cell ICP-MS; HALF-SANDWICH IRIDIUM(III); PHOTODYNAMIC THERAPY; POLYPYRIDYL COMPLEXES; PHOTOSENSITIZERS; MECHANISMS; PROBE;
D O I
10.1002/anie.202202098
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Quantifying the content of metal-based anticancer drugs within single cancer cells remains a challenge. Here, we used single-cell inductively coupled plasma mass spectrometry to study the uptake and retention of mononuclear (Ir1) and dinuclear (Ir2) Ir-III photoredox catalysts. This method allowed rapid and precise quantification of the drug in individual cancer cells. Importantly, Ir2 showed a significant synergism but not an additive effect for NAD(P)H photocatalytic oxidation. The lysosome-targeting Ir2 showed low dark toxicity in vitro and in vivo. Ir2 exhibited high photocatalytic therapeutic efficiency at 525 nm with an excellent photo-index in vitro and in tumor-bearing mice model. Interestingly, the photocatalytic anticancer profile of the dinuclear Ir2 was much better than the mononuclear Ir1, indicating for the first time that dinuclear metal-based photocatalysts can be applied for photocatalytic anticancer treatment.
引用
收藏
页数:8
相关论文
共 70 条
[1]  
[Anonymous], 2015, ANGEW CHEM, V127, P14255
[2]  
[Anonymous], 2020, ANGEW CHEM, V132, P61
[3]  
[Anonymous], 2018, ANGEW CHEM, V130, P11694
[4]  
[Anonymous], 2019, ANGEW CHEM, V131, P6377
[5]   Transfer hydrogenation catalysis in cells [J].
Banerjee, Samya ;
Sadler, Peter J. .
RSC CHEMICAL BIOLOGY, 2021, 2 (01) :12-29
[6]   Inductively Coupled Plasma Mass Spectrometry [J].
Beauchemin, Diane .
ANALYTICAL CHEMISTRY, 2010, 82 (12) :4786-4810
[7]   Exploring the Phototoxicity of Hypoxic Active Iridium(III)-Based Sensitizers in 3D Tumor Spheroids [J].
Bevernaegie, Robin ;
Doix, Bastien ;
Bastien, Estelle ;
Diman, Aurelie ;
Decottignies, Anabelle ;
Feron, Olivier ;
Elias, Benjamin .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2019, 141 (46) :18486-18491
[8]   Mitochondria as multifaceted regulators of cell death [J].
Bock, Florian J. ;
Tait, Stephen W. G. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2020, 21 (02) :85-100
[9]   The ever-increasing importance of cancer as a leading cause of premature death worldwide [J].
Bray, Freddie ;
Laversanne, Mathieu ;
Weiderpass, Elisabete ;
Soerjomataram, Isabelle .
CANCER, 2021, 127 (16) :3029-3030
[10]   Towards the overcoming of anticancer drug resistance mediated by p53 mutations [J].
Cao, Xin ;
Hou, Jiayun ;
An, Quanlin ;
Assaraf, Yehuda G. ;
Wang, Xiangdong .
DRUG RESISTANCE UPDATES, 2020, 49